Adamas pharmaceuticals inc (ADMS)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Revenues:
Total revenues

0

-

-

-

0

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total net revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,059

1,689

1,865

1,916

31,693

31,140

55,896

55,846

65,655

65,601

40,688

71,095

0

0

0

Costs and operating expenses:
Cost of product sales

2,628

2,469

2,462

1,633

1,021

633

198

98

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product sales

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

22,285

30,034

35,451

41,118

42,326

39,300

35,148

29,898

27,268

27,168

27,770

28,748

30,796

31,230

33,880

36,403

35,884

35,895

34,715

30,167

26,635

21,860

15,716

11,691

8,090

7,410

0

0

0

Selling, general and administrative, net

111,233

114,369

111,666

107,977

110,460

109,135

104,542

93,115

78,531

61,312

45,667

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total costs and operating expenses

136,146

146,872

149,579

150,728

153,807

149,068

132,977

113,968

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27,392

25,180

-

21,316

19,866

17,282

15,472

13,337

10,555

8,656

6,667

0

0

0

Total costs and operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

63,625

-

62,813

63,795

61,064

59,353

56,031

50,033

43,917

37,332

29,053

22,246

16,746

14,077

0

0

0

Loss from operations

-78,693

-92,235

-97,975

-102,444

-110,649

-115,022

-118,606

-112,441

-102,717

-87,926

-74,336

-66,457

-63,228

-60,984

-61,754

-62,106

-59,199

-57,437

-24,338

-18,893

11,979

18,514

36,602

43,355

23,942

57,018

0

0

0

Interest and other income, net

-1,454

-2,093

-2,153

-2,562

-2,960

-3,115

-3,017

-2,935

-2,025

-1,351

-1,483

-893

-855

-811

-691

-527

-445

-363

-149

-63

151

917

0

0

0

-

-

-

-

Interest expense

14,937

15,044

15,172

16,682

17,997

19,092

17,563

13,854

9,471

4,645

2,406

729

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-57,074

-24,189

-18,830

11,828

17,597

32,309

38,637

18,769

52,112

0

0

0

Benefit for income taxes

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-5,272

7,192

7,249

7,427

7,374

873

1,083

997

1,191

0

0

0

Net loss

-92,176

-105,186

-110,994

-116,564

-125,686

-130,999

-131,473

-121,681

-108,433

-89,490

-75,093

-66,127

-62,258

-60,058

-55,788

-56,253

-53,428

-51,802

-31,381

-26,079

4,401

10,223

31,436

37,554

17,772

50,921

0

0

0

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

33,068

0

0

0

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

35,353

0

0

0

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.69

0.79

-0.57

1.05

-0.67

2.33

-0.36

-0.35

1.86

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.69

0.89

-0.57

0.88

-0.67

2.00

-0.36

-0.35

1.70

Net loss per share, basic and diluted (in dollars per share)

-0.59

-0.83

-0.99

-0.90

-1.08

-1.04

-1.22

-1.26

-1.35

-1.28

-1.04

-0.93

-0.72

-0.68

-0.66

-0.78

-0.65

-

-0.81

-0.78

-

-

-

-

-

-

-

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,643

17,432

16,787

15,604

9,525

9,512

9,510

9,506

9,496

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,643

23,526

16,787

18,590

9,525

17,410

9,510

9,506

10,798

Weighted average shares used in computing net loss per share, basic and diluted (in shares)

28,030

27,898

27,778

27,579

27,453

27,377

27,266

27,040

25,861

23,065

22,569

22,392

22,206

22,000

21,941

21,650

21,253

-

18,395

17

-

-

-

-

-

-

-

-

-

Product sales
Total revenues

-

-

51,604

48,284

-

34,046

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-